India and Greater South Asia Services
The practice integrates Barnes & Thornburg’s full-service capabilities, including:
- Corporate and commercial matters, including mergers and acquisitions, divestitures, joint ventures, private equity and venture capital investments, financing, market-entry structures, and commercial contracts.
- Cross-border internal and government investigations, anti-corruption matters, securities enforcement including accounting irregularities and insider trading, corporate governance, healthcare fraud and abuse, and compliance program design.
- Foreign investment approvals, government incentive negotiations, and real estate and site selection.
- Complex commercial litigation, product liability, toxic tort and mass tort defense, and class actions.
- Export controls, economic sanctions, customs and tariff compliance, and trade-related due diligence.
- Healthcare and life sciences regulatory compliance and government investigations, transactions and business strategy, and litigation and disputes.
- Intellectual property registration, licensing, and enforcement.
- U.S. immigration law, including affirmative filings for executives and investors, counseling on sponsorship strategies, and compliance with immigration rules.
- Labor and employment matters.
Across these matters, our value is integration and cultural sensitivity: clients receive the depth of a national full-service firm, coordinated across practices and time zones, paired with lawyers who understand the business norms and practical expectations that shape India and Greater South Asia-related work. We are accustomed to collaborating with local counsel, government stakeholders, business leaders, economic development teams, and in-house decision makers to deliver seamless support when and where clients need it. That combination of cultural fluency, regional commitment, and disciplined legal execution helps clients mitigate risks, seize opportunities, and operate across jurisdictions.
Additionally, Barnes & Thornburg’s experience working with clients from many other geographic regions, including Japan, Europe, and Latin America, is an asset to Indian companies that are now used to working closely with organizations from these regions as investment in India grows.
Representative Matters
- Represented a sports company in the formation of a $400 million investment vehicle to raise financing to complete the acquisition of a majority interest in a cricket team in the Indian Premier League.
- Advised a Mumbai-based asset manager on general regulatory matters, U.S. fund formation, the establishment of a U.S. subsidiary, and a private placement to U.S. investors of interests in an alternative investment fund located in Gujarat International Finance Tec-City.
- Represented an Indian textile manufacturing company in settlement payment disputes and collections matters with a buyer of its clothing products in the U.S.
- Represented a consumer brand company based in the UK and India in connection with its acquisition of a U.S. brand business.
- Represented an Indian company specializing in clean energy technology in the formation of a U.S. subsidiary.
- Represented a major Indian public sector bank in multiple investigations by the U.S. Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) regarding compliance with economic sanctions administered by OFAC.
- Represented a global payments company in connection with investigations by various Indian regulatory and law enforcement authorities relating to tax, foreign exchange, and money laundering allegations.
- Represented a global engineering company in connection with U.S. Department of Justice (“DOJ”) and U.S. Securities and Exchange Commission (“SEC”) investigations into allegations of potential improper payments in India.
- Conducted an independent investigation into allegations of bribery and corruption at various locations across India on behalf of a global information technology and outsourcing company.
- Represented the former CEO of an India-based technology company in connection with DOJ and SEC investigations into allegations of potential improper payments in India.
- Advised an India-based life sciences company in connection with a U.S. Food and Drug Administration (“FDA”) inquiry.
- Advised and represented Indian companies establishing U.S. subsidiaries with securing L-1 visas and permanent residency for multinational transfers.